nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—CYP3A5—Artemether—malaria	0.0488	0.173	CbGbCtD
Crizotinib—CYP3A4—Clindamycin—malaria	0.0389	0.138	CbGbCtD
Crizotinib—CYP3A5—Quinine—malaria	0.0295	0.105	CbGbCtD
Crizotinib—CYP3A5—Dapsone—malaria	0.0224	0.0793	CbGbCtD
Crizotinib—CYP3A4—Sulfadiazine—malaria	0.0224	0.0792	CbGbCtD
Crizotinib—ABCB1—Quinine—malaria	0.0192	0.0681	CbGbCtD
Crizotinib—CYP3A4—Artemether—malaria	0.019	0.0673	CbGbCtD
Crizotinib—CYP3A4—Proguanil—malaria	0.0179	0.0633	CbGbCtD
Crizotinib—CYP3A4—Doxycycline—malaria	0.0169	0.06	CbGbCtD
Crizotinib—ABCB1—Quinidine—malaria	0.0169	0.0598	CbGbCtD
Crizotinib—CYP3A4—Quinine—malaria	0.0115	0.0408	CbGbCtD
Crizotinib—CYP3A4—Quinidine—malaria	0.0101	0.0359	CbGbCtD
Crizotinib—CYP3A4—Dapsone—malaria	0.00873	0.0309	CbGbCtD
Crizotinib—Localised oedema—Clindamycin—malaria	0.00775	0.0411	CcSEcCtD
Crizotinib—Localised oedema—Quinidine barbiturate—malaria	0.00686	0.0364	CcSEcCtD
Crizotinib—Periorbital oedema—Sulfadiazine—malaria	0.00665	0.0352	CcSEcCtD
Crizotinib—Disorder sight—Quinidine—malaria	0.00403	0.0214	CcSEcCtD
Crizotinib—Disorder sight—Quinine—malaria	0.00403	0.0214	CcSEcCtD
Crizotinib—Burning sensation—Sulfadiazine—malaria	0.00378	0.0201	CcSEcCtD
Crizotinib—Disorder sight—Quinidine barbiturate—malaria	0.00364	0.0193	CcSEcCtD
Crizotinib—CDK7—Sulfathiazole—Sulfadiazine—malaria	0.00298	0.608	CbGdCrCtD
Crizotinib—Hepatotoxicity—Quinidine—malaria	0.00249	0.0132	CcSEcCtD
Crizotinib—Hepatotoxicity—Quinine—malaria	0.00249	0.0132	CcSEcCtD
Crizotinib—Abscess—Clindamycin—malaria	0.00247	0.0131	CcSEcCtD
Crizotinib—Sepsis—Sulfadiazine—malaria	0.00228	0.0121	CcSEcCtD
Crizotinib—Hepatotoxicity—Quinidine barbiturate—malaria	0.00224	0.0119	CcSEcCtD
Crizotinib—Hepatobiliary disease—Proguanil—malaria	0.0021	0.0111	CcSEcCtD
Crizotinib—Leukopenia—Pyrimethamine—malaria	0.00199	0.0105	CcSEcCtD
Crizotinib—CDK7—Sulfathiazole—Dapsone—malaria	0.00192	0.392	CbGdCrCtD
Crizotinib—Photophobia—Quinine—malaria	0.0018	0.00955	CcSEcCtD
Crizotinib—Photophobia—Quinidine—malaria	0.0018	0.00955	CcSEcCtD
Crizotinib—Mediastinal disorder—Proguanil—malaria	0.00179	0.0095	CcSEcCtD
Crizotinib—Respiratory failure—Quinidine barbiturate—malaria	0.00177	0.00935	CcSEcCtD
Crizotinib—Malnutrition—Proguanil—malaria	0.00173	0.00917	CcSEcCtD
Crizotinib—Photophobia—Quinidine barbiturate—malaria	0.00163	0.00862	CcSEcCtD
Crizotinib—Decreased appetite—Pyrimethamine—malaria	0.00158	0.00835	CcSEcCtD
Crizotinib—Visual disturbance—Quinine—malaria	0.00147	0.0078	CcSEcCtD
Crizotinib—Visual disturbance—Quinidine—malaria	0.00147	0.0078	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00146	0.00776	CcSEcCtD
Crizotinib—Neuropathy peripheral—Sulfadiazine—malaria	0.00144	0.00764	CcSEcCtD
Crizotinib—Diplopia—Quinine—malaria	0.00139	0.00739	CcSEcCtD
Crizotinib—Diplopia—Quinidine—malaria	0.00139	0.00739	CcSEcCtD
Crizotinib—Nervous system disorder—Proguanil—malaria	0.00139	0.00734	CcSEcCtD
Crizotinib—Skin disorder—Proguanil—malaria	0.00137	0.00727	CcSEcCtD
Crizotinib—Visual disturbance—Quinidine barbiturate—malaria	0.00133	0.00703	CcSEcCtD
Crizotinib—Muscular weakness—Dapsone—malaria	0.0013	0.00687	CcSEcCtD
Crizotinib—Diplopia—Quinidine barbiturate—malaria	0.00126	0.00667	CcSEcCtD
Crizotinib—Muscular weakness—Quinidine—malaria	0.00123	0.00652	CcSEcCtD
Crizotinib—Muscular weakness—Quinine—malaria	0.00123	0.00652	CcSEcCtD
Crizotinib—Decreased appetite—Proguanil—malaria	0.00123	0.00651	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Proguanil—malaria	0.00122	0.00646	CcSEcCtD
Crizotinib—Vomiting—Pyrimethamine—malaria	0.00115	0.00611	CcSEcCtD
Crizotinib—Neutropenia—Clindamycin—malaria	0.00115	0.00609	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Clindamycin—malaria	0.00114	0.00605	CcSEcCtD
Crizotinib—Neutropenia—Quinine—malaria	0.00113	0.00597	CcSEcCtD
Crizotinib—Neutropenia—Quinidine—malaria	0.00113	0.00597	CcSEcCtD
Crizotinib—Body temperature increased—Proguanil—malaria	0.00112	0.00592	CcSEcCtD
Crizotinib—Neuropathy peripheral—Dapsone—malaria	0.00111	0.00588	CcSEcCtD
Crizotinib—Muscular weakness—Quinidine barbiturate—malaria	0.00111	0.00588	CcSEcCtD
Crizotinib—Leukopenia—Sulfadiazine—malaria	0.00103	0.00545	CcSEcCtD
Crizotinib—Neutropenia—Quinidine barbiturate—malaria	0.00102	0.00539	CcSEcCtD
Crizotinib—Bradycardia—Quinine—malaria	0.000982	0.0052	CcSEcCtD
Crizotinib—Bradycardia—Quinidine—malaria	0.000982	0.0052	CcSEcCtD
Crizotinib—Infestation NOS—Pentoxifylline—malaria	0.000968	0.00513	CcSEcCtD
Crizotinib—Infestation—Pentoxifylline—malaria	0.000968	0.00513	CcSEcCtD
Crizotinib—Diarrhoea—Proguanil—malaria	0.000967	0.00512	CcSEcCtD
Crizotinib—Urinary tract disorder—Quinidine—malaria	0.000952	0.00505	CcSEcCtD
Crizotinib—Urinary tract disorder—Quinine—malaria	0.000952	0.00505	CcSEcCtD
Crizotinib—Urethral disorder—Quinidine—malaria	0.000945	0.00501	CcSEcCtD
Crizotinib—Urethral disorder—Quinine—malaria	0.000945	0.00501	CcSEcCtD
Crizotinib—Visual impairment—Quinine—malaria	0.000929	0.00492	CcSEcCtD
Crizotinib—Visual impairment—Quinidine—malaria	0.000929	0.00492	CcSEcCtD
Crizotinib—Hepatobiliary disease—Pentoxifylline—malaria	0.000915	0.00485	CcSEcCtD
Crizotinib—Eye disorder—Quinidine—malaria	0.000901	0.00478	CcSEcCtD
Crizotinib—Eye disorder—Quinine—malaria	0.000901	0.00478	CcSEcCtD
Crizotinib—Vomiting—Proguanil—malaria	0.000898	0.00476	CcSEcCtD
Crizotinib—Cardiac disorder—Quinine—malaria	0.000895	0.00474	CcSEcCtD
Crizotinib—Cardiac disorder—Quinidine—malaria	0.000895	0.00474	CcSEcCtD
Crizotinib—Rash—Proguanil—malaria	0.000891	0.00472	CcSEcCtD
Crizotinib—Dermatitis—Proguanil—malaria	0.00089	0.00472	CcSEcCtD
Crizotinib—Bradycardia—Quinidine barbiturate—malaria	0.000886	0.0047	CcSEcCtD
Crizotinib—Mediastinal disorder—Quinine—malaria	0.000869	0.00461	CcSEcCtD
Crizotinib—Mediastinal disorder—Quinidine—malaria	0.000869	0.00461	CcSEcCtD
Crizotinib—Urinary tract disorder—Quinidine barbiturate—malaria	0.00086	0.00455	CcSEcCtD
Crizotinib—Urethral disorder—Quinidine barbiturate—malaria	0.000853	0.00452	CcSEcCtD
Crizotinib—Malnutrition—Quinine—malaria	0.00084	0.00445	CcSEcCtD
Crizotinib—Malnutrition—Quinidine—malaria	0.00084	0.00445	CcSEcCtD
Crizotinib—Nausea—Proguanil—malaria	0.000839	0.00445	CcSEcCtD
Crizotinib—Visual impairment—Quinidine barbiturate—malaria	0.000839	0.00444	CcSEcCtD
Crizotinib—Dysgeusia—Clindamycin—malaria	0.000838	0.00444	CcSEcCtD
Crizotinib—Vision blurred—Dapsone—malaria	0.000834	0.00442	CcSEcCtD
Crizotinib—MAP4K5—saliva-secreting gland—malaria	0.00082	0.00315	CbGeAlD
Crizotinib—MAP4K1—blood—malaria	0.000817	0.00314	CbGeAlD
Crizotinib—EPHB4—hematopoietic system—malaria	0.000817	0.00314	CbGeAlD
Crizotinib—Decreased appetite—Sulfadiazine—malaria	0.000815	0.00432	CcSEcCtD
Crizotinib—Eye disorder—Quinidine barbiturate—malaria	0.000813	0.00431	CcSEcCtD
Crizotinib—JAK2—hematopoietic system—malaria	0.000812	0.00312	CbGeAlD
Crizotinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.00081	0.00429	CcSEcCtD
Crizotinib—Cardiac disorder—Quinidine barbiturate—malaria	0.000808	0.00428	CcSEcCtD
Crizotinib—EPHA2—hematopoietic system—malaria	0.000802	0.00308	CbGeAlD
Crizotinib—IGF1R—blood—malaria	0.000802	0.00308	CbGeAlD
Crizotinib—PTK2B—kidney—malaria	0.000799	0.00307	CbGeAlD
Crizotinib—AURKA—digestive system—malaria	0.000798	0.00307	CbGeAlD
Crizotinib—MET—liver—malaria	0.000798	0.00307	CbGeAlD
Crizotinib—Vision blurred—Quinidine—malaria	0.000791	0.00419	CcSEcCtD
Crizotinib—Vision blurred—Quinine—malaria	0.000791	0.00419	CcSEcCtD
Crizotinib—Anaemia—Clindamycin—malaria	0.000791	0.00419	CcSEcCtD
Crizotinib—MAP4K1—bone marrow—malaria	0.000791	0.00304	CbGeAlD
Crizotinib—MAP4K2—blood—malaria	0.00079	0.00304	CbGeAlD
Crizotinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000784	0.00416	CcSEcCtD
Crizotinib—EPHB6—saliva-secreting gland—malaria	0.000783	0.00301	CbGeAlD
Crizotinib—MAP3K3—hematopoietic system—malaria	0.000782	0.00301	CbGeAlD
Crizotinib—MAP4K5—hematopoietic system—malaria	0.000782	0.00301	CbGeAlD
Crizotinib—TEK—hematopoietic system—malaria	0.000782	0.00301	CbGeAlD
Crizotinib—STK3—blood—malaria	0.00078	0.003	CbGeAlD
Crizotinib—Arrhythmia—Pentoxifylline—malaria	0.000776	0.00411	CcSEcCtD
Crizotinib—CDK7—liver—malaria	0.000771	0.00296	CbGeAlD
Crizotinib—Leukopenia—Clindamycin—malaria	0.000766	0.00406	CcSEcCtD
Crizotinib—TAOK2—liver—malaria	0.000765	0.00294	CbGeAlD
Crizotinib—MAP4K2—bone marrow—malaria	0.000765	0.00294	CbGeAlD
Crizotinib—PRKD1—brain—malaria	0.000761	0.00293	CbGeAlD
Crizotinib—AURKA—blood—malaria	0.00076	0.00292	CbGeAlD
Crizotinib—Malnutrition—Quinidine barbiturate—malaria	0.000758	0.00401	CcSEcCtD
Crizotinib—YES1—saliva-secreting gland—malaria	0.000757	0.00291	CbGeAlD
Crizotinib—TESK1—blood—malaria	0.000754	0.0029	CbGeAlD
Crizotinib—Syncope—Quinine—malaria	0.000753	0.00399	CcSEcCtD
Crizotinib—Syncope—Quinidine—malaria	0.000753	0.00399	CcSEcCtD
Crizotinib—Leukopenia—Quinidine—malaria	0.000752	0.00398	CcSEcCtD
Crizotinib—Leukopenia—Quinine—malaria	0.000752	0.00398	CcSEcCtD
Crizotinib—SIK2—brain—malaria	0.000751	0.00289	CbGeAlD
Crizotinib—LIMK1—brain—malaria	0.000751	0.00289	CbGeAlD
Crizotinib—TAOK3—saliva-secreting gland—malaria	0.000747	0.00287	CbGeAlD
Crizotinib—Body temperature increased—Sulfadiazine—malaria	0.000741	0.00393	CcSEcCtD
Crizotinib—Dysgeusia—Pentoxifylline—malaria	0.000741	0.00392	CcSEcCtD
Crizotinib—Loss of consciousness—Quinine—malaria	0.000738	0.00391	CcSEcCtD
Crizotinib—Loss of consciousness—Quinidine—malaria	0.000738	0.00391	CcSEcCtD
Crizotinib—ACVR1B—liver—malaria	0.000737	0.00283	CbGeAlD
Crizotinib—TBK1—kidney—malaria	0.000736	0.00283	CbGeAlD
Crizotinib—PTK2—kidney—malaria	0.000736	0.00283	CbGeAlD
Crizotinib—AURKA—bone marrow—malaria	0.000735	0.00283	CbGeAlD
Crizotinib—MERTK—blood—malaria	0.000733	0.00282	CbGeAlD
Crizotinib—PRKD3—brain—malaria	0.000732	0.00281	CbGeAlD
Crizotinib—TYK2—kidney—malaria	0.000731	0.00281	CbGeAlD
Crizotinib—YES1—hematopoietic system—malaria	0.000722	0.00278	CbGeAlD
Crizotinib—LIMK2—blood—malaria	0.000717	0.00276	CbGeAlD
Crizotinib—STK10—hematopoietic system—malaria	0.000716	0.00275	CbGeAlD
Crizotinib—NUAK2—blood—malaria	0.000714	0.00275	CbGeAlD
Crizotinib—DSTYK—brain—malaria	0.000714	0.00274	CbGeAlD
Crizotinib—Vision blurred—Quinidine barbiturate—malaria	0.000714	0.00378	CcSEcCtD
Crizotinib—TAOK3—hematopoietic system—malaria	0.000713	0.00274	CbGeAlD
Crizotinib—Vision blurred—Pentoxifylline—malaria	0.000713	0.00378	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00071	0.00376	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00071	0.00376	CcSEcCtD
Crizotinib—MAP3K12—blood—malaria	0.000709	0.00273	CbGeAlD
Crizotinib—ACVR1—blood—malaria	0.000709	0.00273	CbGeAlD
Crizotinib—FLT3—blood—malaria	0.000709	0.00273	CbGeAlD
Crizotinib—MERTK—bone marrow—malaria	0.000709	0.00273	CbGeAlD
Crizotinib—RPS6KB1—kidney—malaria	0.000708	0.00272	CbGeAlD
Crizotinib—Anaemia—Pentoxifylline—malaria	0.000699	0.0037	CcSEcCtD
Crizotinib—LTK—brain—malaria	0.000698	0.00268	CbGeAlD
Crizotinib—CASK—brain—malaria	0.000698	0.00268	CbGeAlD
Crizotinib—SRC—hematopoietic system—malaria	0.000695	0.00267	CbGeAlD
Crizotinib—NUAK2—bone marrow—malaria	0.000691	0.00266	CbGeAlD
Crizotinib—STK4—liver—malaria	0.00069	0.00265	CbGeAlD
Crizotinib—ACVR1—bone marrow—malaria	0.000686	0.00264	CbGeAlD
Crizotinib—FLT3—bone marrow—malaria	0.000686	0.00264	CbGeAlD
Crizotinib—Oedema—Quinidine—malaria	0.000685	0.00363	CcSEcCtD
Crizotinib—Oedema—Quinine—malaria	0.000685	0.00363	CcSEcCtD
Crizotinib—Syncope—Quinidine barbiturate—malaria	0.000679	0.0036	CcSEcCtD
Crizotinib—PTK2B—digestive system—malaria	0.000678	0.00261	CbGeAlD
Crizotinib—Leukopenia—Quinidine barbiturate—malaria	0.000678	0.00359	CcSEcCtD
Crizotinib—ABL2—blood—malaria	0.000677	0.0026	CbGeAlD
Crizotinib—Leukopenia—Pentoxifylline—malaria	0.000677	0.00359	CcSEcCtD
Crizotinib—MAPK7—brain—malaria	0.000676	0.0026	CbGeAlD
Crizotinib—Shock—Quinine—malaria	0.000674	0.00357	CcSEcCtD
Crizotinib—Shock—Quinidine—malaria	0.000674	0.00357	CcSEcCtD
Crizotinib—RIPK2—digestive system—malaria	0.000673	0.00259	CbGeAlD
Crizotinib—Nervous system disorder—Quinine—malaria	0.000672	0.00356	CcSEcCtD
Crizotinib—Nervous system disorder—Quinidine—malaria	0.000672	0.00356	CcSEcCtD
Crizotinib—EPHB4—kidney—malaria	0.00067	0.00257	CbGeAlD
Crizotinib—EPHA8—brain—malaria	0.000669	0.00257	CbGeAlD
Crizotinib—FES—brain—malaria	0.000669	0.00257	CbGeAlD
Crizotinib—BMP2K—blood—malaria	0.000669	0.00257	CbGeAlD
Crizotinib—Loss of consciousness—Quinidine barbiturate—malaria	0.000666	0.00353	CcSEcCtD
Crizotinib—Skin disorder—Quinidine—malaria	0.000666	0.00353	CcSEcCtD
Crizotinib—Skin disorder—Quinine—malaria	0.000666	0.00353	CcSEcCtD
Crizotinib—JAK2—kidney—malaria	0.000665	0.00256	CbGeAlD
Crizotinib—FER—liver—malaria	0.000652	0.00251	CbGeAlD
Crizotinib—LYN—liver—malaria	0.000649	0.00249	CbGeAlD
Crizotinib—BMP2K—bone marrow—malaria	0.000647	0.00249	CbGeAlD
Crizotinib—PTK2B—blood—malaria	0.000646	0.00248	CbGeAlD
Crizotinib—TNK1—liver—malaria	0.000646	0.00248	CbGeAlD
Crizotinib—Diarrhoea—Sulfadiazine—malaria	0.000642	0.0034	CcSEcCtD
Crizotinib—TEK—kidney—malaria	0.000641	0.00246	CbGeAlD
Crizotinib—RIPK2—blood—malaria	0.000641	0.00246	CbGeAlD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000641	0.00339	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000639	0.00339	CcSEcCtD
Crizotinib—MET—brain—malaria	0.000633	0.00243	CbGeAlD
Crizotinib—IGF1R—liver—malaria	0.000627	0.00241	CbGeAlD
Crizotinib—TNK2—liver—malaria	0.000627	0.00241	CbGeAlD
Crizotinib—PTK2B—bone marrow—malaria	0.000625	0.0024	CbGeAlD
Crizotinib—PTK2—digestive system—malaria	0.000625	0.0024	CbGeAlD
Crizotinib—TBK1—digestive system—malaria	0.000625	0.0024	CbGeAlD
Crizotinib—CSF1R—hematopoietic system—malaria	0.000624	0.0024	CbGeAlD
Crizotinib—Dyspnoea—Clindamycin—malaria	0.000623	0.0033	CcSEcCtD
Crizotinib—TYK2—digestive system—malaria	0.00062	0.00238	CbGeAlD
Crizotinib—RIPK2—bone marrow—malaria	0.00062	0.00238	CbGeAlD
Crizotinib—EPHA4—blood—malaria	0.000619	0.00238	CbGeAlD
Crizotinib—Oedema—Quinidine barbiturate—malaria	0.000618	0.00328	CcSEcCtD
Crizotinib—MAP4K2—liver—malaria	0.000618	0.00238	CbGeAlD
Crizotinib—Oedema—Pentoxifylline—malaria	0.000617	0.00327	CcSEcCtD
Crizotinib—Dyspepsia—Clindamycin—malaria	0.000615	0.00326	CcSEcCtD
Crizotinib—Infection—Pentoxifylline—malaria	0.000613	0.00325	CcSEcCtD
Crizotinib—CDK7—brain—malaria	0.000612	0.00235	CbGeAlD
Crizotinib—Dyspnoea—Quinine—malaria	0.000611	0.00324	CcSEcCtD
Crizotinib—Dyspnoea—Quinidine—malaria	0.000611	0.00324	CcSEcCtD
Crizotinib—TIE1—liver—malaria	0.00061	0.00234	CbGeAlD
Crizotinib—STK3—liver—malaria	0.00061	0.00234	CbGeAlD
Crizotinib—Shock—Quinidine barbiturate—malaria	0.000608	0.00322	CcSEcCtD
Crizotinib—MAP3K2—blood—malaria	0.000608	0.00233	CbGeAlD
Crizotinib—Shock—Pentoxifylline—malaria	0.000607	0.00322	CcSEcCtD
Crizotinib—TAOK2—brain—malaria	0.000607	0.00233	CbGeAlD
Crizotinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000606	0.00321	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Clindamycin—malaria	0.000603	0.0032	CcSEcCtD
Crizotinib—Fatigue—Clindamycin—malaria	0.000602	0.00319	CcSEcCtD
Crizotinib—RPS6KB1—digestive system—malaria	0.000601	0.00231	CbGeAlD
Crizotinib—Skin disorder—Quinidine barbiturate—malaria	0.000601	0.00318	CcSEcCtD
Crizotinib—Skin disorder—Pentoxifylline—malaria	0.0006	0.00318	CcSEcCtD
Crizotinib—Constipation—Clindamycin—malaria	0.000597	0.00316	CcSEcCtD
Crizotinib—FGR—digestive system—malaria	0.000597	0.00229	CbGeAlD
Crizotinib—Vomiting—Sulfadiazine—malaria	0.000596	0.00316	CcSEcCtD
Crizotinib—Decreased appetite—Quinidine—malaria	0.000596	0.00316	CcSEcCtD
Crizotinib—Decreased appetite—Quinine—malaria	0.000596	0.00316	CcSEcCtD
Crizotinib—PTK2—blood—malaria	0.000595	0.00229	CbGeAlD
Crizotinib—TBK1—blood—malaria	0.000595	0.00229	CbGeAlD
Crizotinib—AURKA—liver—malaria	0.000594	0.00228	CbGeAlD
Crizotinib—YES1—kidney—malaria	0.000592	0.00228	CbGeAlD
Crizotinib—Gastrointestinal disorder—Quinidine—malaria	0.000592	0.00313	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Quinine—malaria	0.000592	0.00313	CcSEcCtD
Crizotinib—Rash—Sulfadiazine—malaria	0.000591	0.00313	CcSEcCtD
Crizotinib—TYK2—blood—malaria	0.000591	0.00227	CbGeAlD
Crizotinib—Dermatitis—Sulfadiazine—malaria	0.000591	0.00313	CcSEcCtD
Crizotinib—TESK1—liver—malaria	0.000589	0.00227	CbGeAlD
Crizotinib—MAP3K2—bone marrow—malaria	0.000588	0.00226	CbGeAlD
Crizotinib—STK10—kidney—malaria	0.000587	0.00225	CbGeAlD
Crizotinib—ACVR1B—brain—malaria	0.000585	0.00225	CbGeAlD
Crizotinib—EPHA3—brain—malaria	0.000585	0.00225	CbGeAlD
Crizotinib—TAOK3—kidney—malaria	0.000585	0.00225	CbGeAlD
Crizotinib—IRAK1—blood—malaria	0.000583	0.00224	CbGeAlD
Crizotinib—TBK1—bone marrow—malaria	0.000576	0.00221	CbGeAlD
Crizotinib—MERTK—liver—malaria	0.000573	0.0022	CbGeAlD
Crizotinib—RPS6KB1—blood—malaria	0.000572	0.0022	CbGeAlD
Crizotinib—TYK2—bone marrow—malaria	0.000572	0.0022	CbGeAlD
Crizotinib—Body temperature increased—Dapsone—malaria	0.000571	0.00302	CcSEcCtD
Crizotinib—SRC—kidney—malaria	0.00057	0.00219	CbGeAlD
Crizotinib—FGR—blood—malaria	0.000569	0.00219	CbGeAlD
Crizotinib—LCK—blood—malaria	0.000569	0.00219	CbGeAlD
Crizotinib—EPHB4—digestive system—malaria	0.000568	0.00218	CbGeAlD
Crizotinib—IRAK1—bone marrow—malaria	0.000564	0.00217	CbGeAlD
Crizotinib—JAK2—digestive system—malaria	0.000564	0.00217	CbGeAlD
Crizotinib—LIMK2—liver—malaria	0.000561	0.00215	CbGeAlD
Crizotinib—NUAK2—liver—malaria	0.000559	0.00215	CbGeAlD
Crizotinib—EPHA6—brain—malaria	0.000558	0.00214	CbGeAlD
Crizotinib—JAK3—brain—malaria	0.000558	0.00214	CbGeAlD
Crizotinib—EPHA2—digestive system—malaria	0.000558	0.00214	CbGeAlD
Crizotinib—Nausea—Sulfadiazine—malaria	0.000557	0.00295	CcSEcCtD
Crizotinib—MAP3K12—liver—malaria	0.000555	0.00213	CbGeAlD
Crizotinib—ACVR1—liver—malaria	0.000555	0.00213	CbGeAlD
Crizotinib—FLT3—liver—malaria	0.000555	0.00213	CbGeAlD
Crizotinib—DCLK1—brain—malaria	0.000555	0.00213	CbGeAlD
Crizotinib—RPS6KB1—bone marrow—malaria	0.000554	0.00213	CbGeAlD
Crizotinib—Body temperature increased—Clindamycin—malaria	0.000552	0.00293	CcSEcCtD
Crizotinib—Dyspnoea—Quinidine barbiturate—malaria	0.000551	0.00292	CcSEcCtD
Crizotinib—PLK4—brain—malaria	0.000551	0.00212	CbGeAlD
Crizotinib—FGR—bone marrow—malaria	0.00055	0.00212	CbGeAlD
Crizotinib—LCK—bone marrow—malaria	0.00055	0.00212	CbGeAlD
Crizotinib—Dyspnoea—Pentoxifylline—malaria	0.00055	0.00292	CcSEcCtD
Crizotinib—STK4—brain—malaria	0.000548	0.00211	CbGeAlD
Crizotinib—SLK—blood—malaria	0.000545	0.0021	CbGeAlD
Crizotinib—STK35—liver—malaria	0.000544	0.00209	CbGeAlD
Crizotinib—Dyspepsia—Pentoxifylline—malaria	0.000543	0.00288	CcSEcCtD
Crizotinib—Body temperature increased—Quinine—malaria	0.000542	0.00287	CcSEcCtD
Crizotinib—Body temperature increased—Quinidine—malaria	0.000542	0.00287	CcSEcCtD
Crizotinib—EPHB4—blood—malaria	0.000541	0.00208	CbGeAlD
Crizotinib—JAK2—blood—malaria	0.000538	0.00207	CbGeAlD
Crizotinib—Decreased appetite—Quinidine barbiturate—malaria	0.000538	0.00285	CcSEcCtD
Crizotinib—Decreased appetite—Pentoxifylline—malaria	0.000537	0.00284	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000534	0.00283	CcSEcCtD
Crizotinib—EPHA2—blood—malaria	0.000531	0.00204	CbGeAlD
Crizotinib—ABL2—liver—malaria	0.00053	0.00204	CbGeAlD
Crizotinib—Constipation—Quinidine barbiturate—malaria	0.000529	0.0028	CcSEcCtD
Crizotinib—Constipation—Pentoxifylline—malaria	0.000528	0.0028	CcSEcCtD
Crizotinib—SLK—bone marrow—malaria	0.000528	0.00203	CbGeAlD
Crizotinib—EPHB4—bone marrow—malaria	0.000524	0.00201	CbGeAlD
Crizotinib—BMP2K—liver—malaria	0.000523	0.00201	CbGeAlD
Crizotinib—CYP3A5—blood plasma—malaria	0.000522	0.00201	CbGeAlD
Crizotinib—JAK2—bone marrow—malaria	0.00052	0.002	CbGeAlD
Crizotinib—MAP3K3—blood—malaria	0.000518	0.00199	CbGeAlD
Crizotinib—TEK—blood—malaria	0.000518	0.00199	CbGeAlD
Crizotinib—MAP4K5—blood—malaria	0.000518	0.00199	CbGeAlD
Crizotinib—TYRO3—brain—malaria	0.000518	0.00199	CbGeAlD
Crizotinib—EPHA5—brain—malaria	0.000518	0.00199	CbGeAlD
Crizotinib—ALK—brain—malaria	0.000518	0.00199	CbGeAlD
Crizotinib—FER—brain—malaria	0.000518	0.00199	CbGeAlD
Crizotinib—ABL1—saliva-secreting gland—malaria	0.000517	0.00199	CbGeAlD
Crizotinib—LYN—brain—malaria	0.000515	0.00198	CbGeAlD
Crizotinib—TNK1—brain—malaria	0.000512	0.00197	CbGeAlD
Crizotinib—MAP4K1—brain—malaria	0.000507	0.00195	CbGeAlD
Crizotinib—MAP3K19—brain—malaria	0.000507	0.00195	CbGeAlD
Crizotinib—BMPR1B—brain—malaria	0.000507	0.00195	CbGeAlD
Crizotinib—PTK2B—liver—malaria	0.000505	0.00194	CbGeAlD
Crizotinib—YES1—digestive system—malaria	0.000502	0.00193	CbGeAlD
Crizotinib—MAP3K3—bone marrow—malaria	0.000501	0.00193	CbGeAlD
Crizotinib—MAP4K5—bone marrow—malaria	0.000501	0.00193	CbGeAlD
Crizotinib—RIPK2—liver—malaria	0.000501	0.00193	CbGeAlD
Crizotinib—Asthenia—Clindamycin—malaria	0.000501	0.00266	CcSEcCtD
Crizotinib—STK10—digestive system—malaria	0.000498	0.00191	CbGeAlD
Crizotinib—IGF1R—brain—malaria	0.000497	0.00191	CbGeAlD
Crizotinib—TNK2—brain—malaria	0.000497	0.00191	CbGeAlD
Crizotinib—TAOK3—digestive system—malaria	0.000496	0.00191	CbGeAlD
Crizotinib—EPHB6—blood—malaria	0.000495	0.0019	CbGeAlD
Crizotinib—ABL1—hematopoietic system—malaria	0.000493	0.0019	CbGeAlD
Crizotinib—Asthenia—Quinidine—malaria	0.000492	0.0026	CcSEcCtD
Crizotinib—Asthenia—Quinine—malaria	0.000492	0.0026	CcSEcCtD
Crizotinib—MAP4K2—brain—malaria	0.00049	0.00188	CbGeAlD
Crizotinib—Body temperature increased—Quinidine barbiturate—malaria	0.000489	0.00259	CcSEcCtD
Crizotinib—Body temperature increased—Pentoxifylline—malaria	0.000488	0.00259	CcSEcCtD
Crizotinib—STK3—brain—malaria	0.000484	0.00186	CbGeAlD
Crizotinib—TIE1—brain—malaria	0.000484	0.00186	CbGeAlD
Crizotinib—SRC—digestive system—malaria	0.000483	0.00186	CbGeAlD
Crizotinib—YES1—blood—malaria	0.000479	0.00184	CbGeAlD
Crizotinib—Diarrhoea—Clindamycin—malaria	0.000478	0.00253	CcSEcCtD
Crizotinib—MAP3K2—liver—malaria	0.000475	0.00183	CbGeAlD
Crizotinib—STK10—blood—malaria	0.000474	0.00182	CbGeAlD
Crizotinib—TAOK3—blood—malaria	0.000472	0.00182	CbGeAlD
Crizotinib—AURKA—brain—malaria	0.000472	0.00181	CbGeAlD
Crizotinib—Diarrhoea—Quinidine—malaria	0.000469	0.00248	CcSEcCtD
Crizotinib—Diarrhoea—Quinine—malaria	0.000469	0.00248	CcSEcCtD
Crizotinib—TESK1—brain—malaria	0.000468	0.0018	CbGeAlD
Crizotinib—TBK1—liver—malaria	0.000465	0.00179	CbGeAlD
Crizotinib—PTK2—liver—malaria	0.000465	0.00179	CbGeAlD
Crizotinib—YES1—bone marrow—malaria	0.000463	0.00178	CbGeAlD
Crizotinib—TYK2—liver—malaria	0.000462	0.00178	CbGeAlD
Crizotinib—Dizziness—Clindamycin—malaria	0.000462	0.00245	CcSEcCtD
Crizotinib—SRC—blood—malaria	0.00046	0.00177	CbGeAlD
Crizotinib—Vomiting—Dapsone—malaria	0.000459	0.00243	CcSEcCtD
Crizotinib—STK10—bone marrow—malaria	0.000459	0.00176	CbGeAlD
Crizotinib—TAOK3—bone marrow—malaria	0.000457	0.00176	CbGeAlD
Crizotinib—IRAK1—liver—malaria	0.000456	0.00175	CbGeAlD
Crizotinib—MERTK—brain—malaria	0.000455	0.00175	CbGeAlD
Crizotinib—Dizziness—Quinidine—malaria	0.000453	0.0024	CcSEcCtD
Crizotinib—Dizziness—Quinine—malaria	0.000453	0.0024	CcSEcCtD
Crizotinib—RPS6KB1—liver—malaria	0.000448	0.00172	CbGeAlD
Crizotinib—LIMK2—brain—malaria	0.000445	0.00171	CbGeAlD
Crizotinib—FGR—liver—malaria	0.000445	0.00171	CbGeAlD
Crizotinib—LCK—liver—malaria	0.000445	0.00171	CbGeAlD
Crizotinib—Vomiting—Clindamycin—malaria	0.000444	0.00235	CcSEcCtD
Crizotinib—Asthenia—Quinidine barbiturate—malaria	0.000444	0.00235	CcSEcCtD
Crizotinib—NUAK2—brain—malaria	0.000443	0.0017	CbGeAlD
Crizotinib—AXL—liver—malaria	0.000443	0.0017	CbGeAlD
Crizotinib—Asthenia—Pentoxifylline—malaria	0.000443	0.00235	CcSEcCtD
Crizotinib—Rash—Clindamycin—malaria	0.00044	0.00233	CcSEcCtD
Crizotinib—MAP3K12—brain—malaria	0.00044	0.00169	CbGeAlD
Crizotinib—ACVR1—brain—malaria	0.00044	0.00169	CbGeAlD
Crizotinib—Dermatitis—Clindamycin—malaria	0.00044	0.00233	CcSEcCtD
Crizotinib—Vomiting—Quinidine—malaria	0.000436	0.00231	CcSEcCtD
Crizotinib—Vomiting—Quinine—malaria	0.000436	0.00231	CcSEcCtD
Crizotinib—CSF1R—digestive system—malaria	0.000434	0.00167	CbGeAlD
Crizotinib—Rash—Quinidine—malaria	0.000432	0.00229	CcSEcCtD
Crizotinib—Rash—Quinine—malaria	0.000432	0.00229	CcSEcCtD
Crizotinib—Dermatitis—Quinine—malaria	0.000432	0.00229	CcSEcCtD
Crizotinib—Dermatitis—Quinidine—malaria	0.000432	0.00229	CcSEcCtD
Crizotinib—STK35—brain—malaria	0.000431	0.00166	CbGeAlD
Crizotinib—Nausea—Dapsone—malaria	0.000429	0.00227	CcSEcCtD
Crizotinib—SLK—liver—malaria	0.000427	0.00164	CbGeAlD
Crizotinib—EPHB4—liver—malaria	0.000423	0.00163	CbGeAlD
Crizotinib—Diarrhoea—Quinidine barbiturate—malaria	0.000423	0.00224	CcSEcCtD
Crizotinib—Diarrhoea—Pentoxifylline—malaria	0.000422	0.00224	CcSEcCtD
Crizotinib—JAK2—liver—malaria	0.00042	0.00162	CbGeAlD
Crizotinib—ABL2—brain—malaria	0.00042	0.00162	CbGeAlD
Crizotinib—EPHA2—liver—malaria	0.000415	0.0016	CbGeAlD
Crizotinib—BMP2K—brain—malaria	0.000415	0.0016	CbGeAlD
Crizotinib—Nausea—Clindamycin—malaria	0.000415	0.0022	CcSEcCtD
Crizotinib—CSF1R—blood—malaria	0.000413	0.00159	CbGeAlD
Crizotinib—Dizziness—Quinidine barbiturate—malaria	0.000409	0.00217	CcSEcCtD
Crizotinib—Dizziness—Pentoxifylline—malaria	0.000408	0.00216	CcSEcCtD
Crizotinib—Nausea—Quinine—malaria	0.000407	0.00216	CcSEcCtD
Crizotinib—Nausea—Quinidine—malaria	0.000407	0.00216	CcSEcCtD
Crizotinib—MAP3K3—liver—malaria	0.000405	0.00156	CbGeAlD
Crizotinib—TEK—liver—malaria	0.000405	0.00156	CbGeAlD
Crizotinib—MAP4K5—liver—malaria	0.000405	0.00156	CbGeAlD
Crizotinib—ABL1—kidney—malaria	0.000404	0.00155	CbGeAlD
Crizotinib—PTK2B—brain—malaria	0.000401	0.00154	CbGeAlD
Crizotinib—CSF1R—bone marrow—malaria	0.0004	0.00154	CbGeAlD
Crizotinib—RIPK2—brain—malaria	0.000398	0.00153	CbGeAlD
Crizotinib—Vomiting—Quinidine barbiturate—malaria	0.000393	0.00208	CcSEcCtD
Crizotinib—Vomiting—Pentoxifylline—malaria	0.000392	0.00208	CcSEcCtD
Crizotinib—CYP3A4—blood plasma—malaria	0.000392	0.00151	CbGeAlD
Crizotinib—Rash—Quinidine barbiturate—malaria	0.00039	0.00207	CcSEcCtD
Crizotinib—Dermatitis—Quinidine barbiturate—malaria	0.00039	0.00206	CcSEcCtD
Crizotinib—Rash—Pentoxifylline—malaria	0.000389	0.00206	CcSEcCtD
Crizotinib—Dermatitis—Pentoxifylline—malaria	0.000389	0.00206	CcSEcCtD
Crizotinib—EPHA4—brain—malaria	0.000384	0.00148	CbGeAlD
Crizotinib—MAP3K2—brain—malaria	0.000377	0.00145	CbGeAlD
Crizotinib—YES1—liver—malaria	0.000374	0.00144	CbGeAlD
Crizotinib—STK10—liver—malaria	0.000371	0.00143	CbGeAlD
Crizotinib—TAOK3—liver—malaria	0.000369	0.00142	CbGeAlD
Crizotinib—TBK1—brain—malaria	0.000369	0.00142	CbGeAlD
Crizotinib—PTK2—brain—malaria	0.000369	0.00142	CbGeAlD
Crizotinib—Nausea—Quinidine barbiturate—malaria	0.000367	0.00195	CcSEcCtD
Crizotinib—TYK2—brain—malaria	0.000367	0.00141	CbGeAlD
Crizotinib—Nausea—Pentoxifylline—malaria	0.000367	0.00194	CcSEcCtD
Crizotinib—IRAK1—brain—malaria	0.000362	0.00139	CbGeAlD
Crizotinib—SRC—liver—malaria	0.00036	0.00138	CbGeAlD
Crizotinib—RPS6KB1—brain—malaria	0.000355	0.00136	CbGeAlD
Crizotinib—FGR—brain—malaria	0.000353	0.00136	CbGeAlD
Crizotinib—AXL—brain—malaria	0.000352	0.00135	CbGeAlD
Crizotinib—ABL1—digestive system—malaria	0.000343	0.00132	CbGeAlD
Crizotinib—SLK—brain—malaria	0.000338	0.0013	CbGeAlD
Crizotinib—EPHB4—brain—malaria	0.000336	0.00129	CbGeAlD
Crizotinib—JAK2—brain—malaria	0.000334	0.00128	CbGeAlD
Crizotinib—EPHA2—brain—malaria	0.00033	0.00127	CbGeAlD
Crizotinib—ABL1—blood—malaria	0.000327	0.00126	CbGeAlD
Crizotinib—CSF1R—liver—malaria	0.000323	0.00124	CbGeAlD
Crizotinib—MAP3K3—brain—malaria	0.000322	0.00124	CbGeAlD
Crizotinib—TEK—brain—malaria	0.000322	0.00124	CbGeAlD
Crizotinib—MAP4K5—brain—malaria	0.000322	0.00124	CbGeAlD
Crizotinib—ABL1—bone marrow—malaria	0.000316	0.00121	CbGeAlD
Crizotinib—EPHB6—brain—malaria	0.000307	0.00118	CbGeAlD
Crizotinib—YES1—brain—malaria	0.000297	0.00114	CbGeAlD
Crizotinib—STK10—brain—malaria	0.000294	0.00113	CbGeAlD
Crizotinib—TAOK3—brain—malaria	0.000293	0.00113	CbGeAlD
Crizotinib—CYP3A5—hematopoietic system—malaria	0.000289	0.00111	CbGeAlD
Crizotinib—SRC—brain—malaria	0.000286	0.0011	CbGeAlD
Crizotinib—ABCB1—blood plasma—malaria	0.000277	0.00107	CbGeAlD
Crizotinib—CSF1R—brain—malaria	0.000256	0.000986	CbGeAlD
Crizotinib—ABL1—liver—malaria	0.000256	0.000982	CbGeAlD
Crizotinib—CYP3A5—kidney—malaria	0.000237	0.000909	CbGeAlD
Crizotinib—CYP3A4—hematopoietic system—malaria	0.000217	0.000833	CbGeAlD
Crizotinib—ABL1—brain—malaria	0.000203	0.000779	CbGeAlD
Crizotinib—CYP3A5—digestive system—malaria	0.000201	0.000772	CbGeAlD
Crizotinib—CYP3A5—blood—malaria	0.000191	0.000735	CbGeAlD
Crizotinib—CYP3A4—kidney—malaria	0.000178	0.000682	CbGeAlD
Crizotinib—ABCB1—hematopoietic system—malaria	0.000153	0.000589	CbGeAlD
Crizotinib—CYP3A4—digestive system—malaria	0.000151	0.000579	CbGeAlD
Crizotinib—CYP3A5—liver—malaria	0.00015	0.000575	CbGeAlD
Crizotinib—CYP3A4—blood—malaria	0.000144	0.000552	CbGeAlD
Crizotinib—ABCB1—kidney—malaria	0.000126	0.000483	CbGeAlD
Crizotinib—CYP3A4—liver—malaria	0.000112	0.000431	CbGeAlD
Crizotinib—ABCB1—digestive system—malaria	0.000107	0.00041	CbGeAlD
Crizotinib—ABCB1—blood—malaria	0.000102	0.00039	CbGeAlD
Crizotinib—ABCB1—bone marrow—malaria	9.83e-05	0.000378	CbGeAlD
Crizotinib—ABCB1—liver—malaria	7.95e-05	0.000305	CbGeAlD
Crizotinib—ABCB1—brain—malaria	6.3e-05	0.000242	CbGeAlD
Crizotinib—SRC—Signaling by FGFR in disease—IL6—malaria	1.49e-05	5.64e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—CD4—malaria	1.49e-05	5.64e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD8A—malaria	1.49e-05	5.64e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—ICAM1—malaria	1.49e-05	5.63e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—DECR1—malaria	1.48e-05	5.62e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IFNG—malaria	1.48e-05	5.62e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IFNG—malaria	1.48e-05	5.6e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by EGFR—IL6—malaria	1.48e-05	5.59e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—CD4—malaria	1.47e-05	5.59e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—CD4—malaria	1.47e-05	5.56e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—CD4—malaria	1.47e-05	5.56e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by EGFR in Cancer—IL6—malaria	1.46e-05	5.54e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by PDGF—IL6—malaria	1.46e-05	5.52e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—ICAM1—malaria	1.44e-05	5.47e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—CD4—malaria	1.44e-05	5.46e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-B—malaria	1.44e-05	5.45e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TLR9—malaria	1.44e-05	5.44e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—CD4—malaria	1.43e-05	5.43e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-B—malaria	1.43e-05	5.43e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—CD4—malaria	1.43e-05	5.41e-05	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—IL6—malaria	1.42e-05	5.39e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL18—malaria	1.42e-05	5.38e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—CD4—malaria	1.42e-05	5.37e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD40LG—malaria	1.41e-05	5.36e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—G6PD—malaria	1.41e-05	5.35e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD36—malaria	1.41e-05	5.34e-05	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—IL2—malaria	1.41e-05	5.34e-05	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—IL6—malaria	1.41e-05	5.33e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD36—malaria	1.4e-05	5.32e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD8A—malaria	1.4e-05	5.3e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—ICAM1—malaria	1.4e-05	5.3e-05	CbGpPWpGaD
Crizotinib—RIPK2—Innate Immune System—IL6—malaria	1.38e-05	5.24e-05	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—TNF—malaria	1.38e-05	5.24e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—CD4—malaria	1.38e-05	5.23e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL1B—malaria	1.37e-05	5.21e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—IL2—malaria	1.37e-05	5.21e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL2—malaria	1.37e-05	5.19e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—KDR—malaria	1.37e-05	5.18e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL1B—malaria	1.35e-05	5.13e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL2—malaria	1.35e-05	5.11e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-B—malaria	1.35e-05	5.1e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—KDR—malaria	1.35e-05	5.1e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—IL2—malaria	1.34e-05	5.1e-05	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—IL6—malaria	1.34e-05	5.09e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HBB—malaria	1.34e-05	5.08e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—IL6—malaria	1.34e-05	5.07e-05	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—IL6—malaria	1.33e-05	5.04e-05	CbGpPWpGaD
Crizotinib—FGR—Innate Immune System—IL6—malaria	1.32e-05	5.02e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL1B—malaria	1.32e-05	5.01e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—NOS2—malaria	1.32e-05	5.01e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD36—malaria	1.32e-05	5e-05	CbGpPWpGaD
Crizotinib—SRC—NGF signalling via TRKA from the plasma membrane—IL6—malaria	1.32e-05	5e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL1B—malaria	1.32e-05	4.99e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL2—malaria	1.32e-05	4.99e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL2—malaria	1.31e-05	4.98e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by NGF—IL6—malaria	1.31e-05	4.96e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—KDR—malaria	1.29e-05	4.88e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CRP—malaria	1.27e-05	4.82e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CRP—malaria	1.27e-05	4.8e-05	CbGpPWpGaD
Crizotinib—LYN—Axon guidance—IL6—malaria	1.27e-05	4.79e-05	CbGpPWpGaD
Crizotinib—ABL1—Axon guidance—IL6—malaria	1.26e-05	4.77e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—KDR—malaria	1.25e-05	4.73e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL18—malaria	1.24e-05	4.72e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD40LG—malaria	1.24e-05	4.7e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—IL2—malaria	1.23e-05	4.68e-05	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—IL6—malaria	1.23e-05	4.65e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD8A—malaria	1.23e-05	4.64e-05	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—IL6—malaria	1.22e-05	4.63e-05	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—IL6—malaria	1.22e-05	4.63e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—TLR4—malaria	1.22e-05	4.62e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—TLR4—malaria	1.21e-05	4.6e-05	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—IL6—malaria	1.21e-05	4.59e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IFNG—malaria	1.21e-05	4.58e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—CD4—malaria	1.21e-05	4.58e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PKLR—malaria	1.2e-05	4.53e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—IFNG—malaria	1.19e-05	4.52e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CRP—malaria	1.19e-05	4.51e-05	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—IL6—malaria	1.18e-05	4.49e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-B—malaria	1.18e-05	4.47e-05	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—IL6—malaria	1.18e-05	4.47e-05	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—IL6—malaria	1.18e-05	4.47e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—ICAM1—malaria	1.17e-05	4.43e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CD4—malaria	1.17e-05	4.43e-05	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—IL6—malaria	1.17e-05	4.42e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—ICAM1—malaria	1.16e-05	4.41e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CD4—malaria	1.16e-05	4.4e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD36—malaria	1.16e-05	4.38e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—CD4—malaria	1.15e-05	4.36e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—IL6—malaria	1.15e-05	4.34e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DHODH—malaria	1.14e-05	4.33e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—TLR4—malaria	1.14e-05	4.32e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IFNG—malaria	1.13e-05	4.29e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TNF—malaria	1.12e-05	4.24e-05	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—IL6—malaria	1.12e-05	4.23e-05	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—IL6—malaria	1.11e-05	4.23e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TNF—malaria	1.11e-05	4.22e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL18—malaria	1.1e-05	4.17e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IFNG—malaria	1.1e-05	4.16e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD40LG—malaria	1.1e-05	4.16e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—ICAM1—malaria	1.09e-05	4.14e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—IL2—malaria	1.09e-05	4.14e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CD4—malaria	1.09e-05	4.14e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD8A—malaria	1.08e-05	4.11e-05	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—IL6—malaria	1.08e-05	4.11e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL1B—malaria	1.08e-05	4.09e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—HPGDS—malaria	1.08e-05	4.08e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL2—malaria	1.07e-05	4.07e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—KDR—malaria	1.07e-05	4.06e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—CD4—malaria	1.07e-05	4.05e-05	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—IL6—malaria	1.07e-05	4.05e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL2—malaria	1.07e-05	4.05e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—G6PD—malaria	1.07e-05	4.04e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL1B—malaria	1.06e-05	4.03e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CD4—malaria	1.06e-05	4.02e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL2—malaria	1.06e-05	4.02e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—KDR—malaria	1.06e-05	4.01e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TNF—malaria	1.05e-05	3.97e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-B—malaria	1.04e-05	3.96e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CRP—malaria	1.04e-05	3.95e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CD4—malaria	1.03e-05	3.89e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.03e-05	3.89e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD36—malaria	1.02e-05	3.88e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—IL6—malaria	1.02e-05	3.87e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—IL6—malaria	1.01e-05	3.84e-05	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—IL6—malaria	1.01e-05	3.84e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL1B—malaria	1.01e-05	3.82e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL2—malaria	1e-05	3.81e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—KDR—malaria	1e-05	3.8e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—NOS2—malaria	1e-05	3.8e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—TLR4—malaria	9.99e-06	3.79e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—DHFR—malaria	9.99e-06	3.79e-05	CbGpPWpGaD
Crizotinib—TBK1—Immune System—IL6—malaria	9.98e-06	3.78e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL2—malaria	9.93e-06	3.76e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—SCARB1—malaria	9.88e-06	3.75e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—IL6—malaria	9.88e-06	3.75e-05	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—IL6—malaria	9.84e-06	3.73e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL1B—malaria	9.79e-06	3.71e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—CD4—malaria	9.79e-06	3.71e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL2—malaria	9.76e-06	3.7e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—KDR—malaria	9.73e-06	3.69e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SLC4A1—malaria	9.72e-06	3.68e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—ICAM1—malaria	9.58e-06	3.63e-05	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—IL6—malaria	9.57e-06	3.63e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CRP—malaria	9.22e-06	3.5e-05	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—IL6—malaria	9.18e-06	3.48e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DECR1—malaria	9.13e-06	3.46e-05	CbGpPWpGaD
Crizotinib—JAK3—Immune System—IL6—malaria	9.03e-06	3.42e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—IL6—malaria	9.03e-06	3.42e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—IL6—malaria	8.99e-06	3.41e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—IL6—malaria	8.93e-06	3.38e-05	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—IL2—malaria	8.91e-06	3.38e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IFNG—malaria	8.89e-06	3.37e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL2—malaria	8.85e-06	3.36e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IFNG—malaria	8.85e-06	3.35e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—TLR4—malaria	8.84e-06	3.35e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—NOS2—malaria	8.77e-06	3.32e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL2—malaria	8.72e-06	3.31e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD4—malaria	8.59e-06	3.25e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD4—malaria	8.55e-06	3.24e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—ICAM1—malaria	8.48e-06	3.21e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—IL6—malaria	8.45e-06	3.2e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL2—malaria	8.35e-06	3.16e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IFNG—malaria	8.32e-06	3.15e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HBB—malaria	8.26e-06	3.13e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HPGDS—malaria	8.12e-06	3.08e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—malaria	8.12e-06	3.08e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL2—malaria	8.1e-06	3.07e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL2—malaria	8.09e-06	3.07e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—IL6—malaria	8.07e-06	3.06e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL6—malaria	8.05e-06	3.05e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD4—malaria	8.04e-06	3.05e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—IL6—malaria	7.97e-06	3.02e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—IL6—malaria	7.94e-06	3.01e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL6—malaria	7.93e-06	3.01e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL1B—malaria	7.93e-06	3.01e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—IL6—malaria	7.9e-06	2.99e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL2—malaria	7.9e-06	2.99e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL1B—malaria	7.89e-06	2.99e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—KDR—malaria	7.88e-06	2.99e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL2—malaria	7.86e-06	2.98e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—IL6—malaria	7.79e-06	2.95e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS2—malaria	7.77e-06	2.94e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL6—malaria	7.74e-06	2.93e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL6—malaria	7.72e-06	2.92e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—DHFR—malaria	7.54e-06	2.86e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—IL6—malaria	7.46e-06	2.83e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—SCARB1—malaria	7.46e-06	2.83e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL1B—malaria	7.42e-06	2.81e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—CD4—malaria	7.42e-06	2.81e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL2—malaria	7.39e-06	2.8e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—KDR—malaria	7.37e-06	2.79e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PKLR—malaria	7.36e-06	2.79e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IFNG—malaria	7.29e-06	2.76e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD4—malaria	7.04e-06	2.67e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL2—malaria	6.95e-06	2.63e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL2—malaria	6.85e-06	2.6e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—G6PD—malaria	6.56e-06	2.49e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—IL6—malaria	6.55e-06	2.48e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—IL6—malaria	6.53e-06	2.48e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1B—malaria	6.5e-06	2.46e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—CD4—malaria	6.5e-06	2.46e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL2—malaria	6.5e-06	2.46e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL2—malaria	6.48e-06	2.45e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—KDR—malaria	6.46e-06	2.45e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IFNG—malaria	6.45e-06	2.45e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL6—malaria	6.31e-06	2.39e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL2—malaria	6.31e-06	2.39e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL6—malaria	6.28e-06	2.38e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD4—malaria	6.23e-06	2.36e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL6—malaria	6.23e-06	2.36e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CD36—malaria	6.2e-06	2.35e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL6—malaria	5.91e-06	2.24e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL6—malaria	5.84e-06	2.21e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—IL6—malaria	5.79e-06	2.19e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1B—malaria	5.75e-06	2.18e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CD4—malaria	5.75e-06	2.18e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL6—malaria	5.73e-06	2.17e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL2—malaria	5.73e-06	2.17e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—KDR—malaria	5.72e-06	2.17e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—malaria	5.29e-06	2.01e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—malaria	5.2e-06	1.97e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—malaria	5.13e-06	1.94e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL2—malaria	5.11e-06	1.94e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HPGDS—malaria	5e-06	1.9e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—malaria	4.91e-06	1.86e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL2—malaria	4.78e-06	1.81e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—malaria	4.76e-06	1.8e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—malaria	4.76e-06	1.8e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CD36—malaria	4.68e-06	1.77e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—malaria	4.64e-06	1.76e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DHFR—malaria	4.64e-06	1.76e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—malaria	4.62e-06	1.75e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SCARB1—malaria	4.6e-06	1.74e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—malaria	4.35e-06	1.65e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL2—malaria	4.19e-06	1.59e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—malaria	4.08e-06	1.55e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—malaria	4.03e-06	1.53e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—malaria	4.01e-06	1.52e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—malaria	3.82e-06	1.45e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—malaria	3.81e-06	1.44e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—malaria	3.71e-06	1.41e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL2—malaria	3.71e-06	1.4e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—malaria	3.51e-06	1.33e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—malaria	3.37e-06	1.28e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—malaria	3.11e-06	1.18e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—malaria	3e-06	1.14e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CD36—malaria	2.88e-06	1.09e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—malaria	2.81e-06	1.06e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—malaria	2.46e-06	9.33e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—malaria	2.18e-06	8.26e-06	CbGpPWpGaD
